DaVita price target raised to $126 from $115 at BofA

BofA raised the firm’s price target on DaVita to $126 from $115 and keeps an Underperform rating on the shares after the company reported adjusted operating income 8% above consensus on better revenue and better margins. The “most important part” of the company’s guidance raise may be assumption of 1%-2% volume growth, says the firm, which reiterates an Underperform rating as it waits to see more proof points on volume improvement.